Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function
Clinical trial NCT07342881 · RECRUITING
Trial details
- NCT number
- NCT07342881
- Sponsor
- Aligos Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2026-06-15
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.